Recent Dow pullback: Social media discussions highlight Procter & Gamble shares dropping sharply last week alongside peers like Honeywell and Walmart, retreating from overbought levels to neutral territory. Despite the decline, the stock remains among the Dow's top performers year-to-date. Investors view this as a healthy correction amid broader market rotations.
Currency headwinds persist: Traders frequently cite the strong U.S. dollar as a challenge for multinationals including PG, pressuring earnings growth despite robust underlying demand. This factor has weighed on recent reports from consumer staples giants. Commentary emphasizes resilience in core business operations.
Dividend king appeal: Enthusiasm surrounds PG's status as a Dividend King with decades of increases, positioning it favorably in polls against high-flyers like Nvidia and Tesla. Users tout its defensive qualities and compounding potential for long-term holders. Stability in uncertain times draws consistent praise.
Note: This discussion summary was generated from an AI condensation of post data.
Procter & Gamble Insider Trading Activity
Procter & Gamble insiders have traded $PG stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.
Here’s a breakdown of recent trading of $PG stock by insiders over the last 6 months:
- JON R MOELLER (Exec. Chairman of the Board) has made 0 purchases and 3 sales selling 184,952 shares for an estimated $29,898,796.
- MARC S. PRITCHARD (Chief Brand Officer) sold 95,903 shares for an estimated $14,495,690
- GARY A COOMBE (CEO - Grooming) has made 0 purchases and 2 sales selling 39,628 shares for an estimated $6,397,141.
- MOSES VICTOR JAVIER AGUILAR (Chf Rsch, Dev & Innov Officer) sold 15,169 shares for an estimated $2,461,608
- MA. FATIMA FRANCISCO (CEO - Baby, Fem & Family Care) has made 0 purchases and 5 sales selling 13,549 shares for an estimated $2,181,199.
- BALAJI PURUSHOTHAMAN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 13,317 shares for an estimated $2,130,880.
- SUSAN STREET WHALEY (Chief Legal Officer & Secy) has made 0 purchases and 2 sales selling 4,217 shares for an estimated $655,028.
- ANDRE SCHULTEN (Chief Financial Officer) has made 0 purchases and 2 sales selling 4,253 shares for an estimated $647,479.
- SHAILESH JEJURIKAR (Chief Operating Officer) sold 3,986 shares for an estimated $606,795
- JENNIFER L. DAVIS (CEO - Health Care) sold 3,227 shares for an estimated $491,251
- R. ALEXANDRA KEITH (CEO - Beauty) has made 0 purchases and 2 sales selling 2,254 shares for an estimated $343,130.
- MATTHEW W. JANZARUK (SVP - Chief Accounting Officer) sold 725 shares for an estimated $108,438
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Procter & Gamble Revenue
Procter & Gamble had revenues of $22.2B in Q2 2026. This is an increase of 1.49% from the same period in the prior year.
You can track PG financials on Quiver Quantitative's PG stock page.
Procter & Gamble Congressional Stock Trading
Members of Congress have traded $PG stock 21 times in the past 6 months. Of those trades, 10 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $PG stock by members of Congress over the last 6 months:
- SENATOR JOHN BOOZMAN sold up to $15,000 on 02/26.
- REPRESENTATIVE LLOYD DOGGETT purchased up to $15,000 on 02/17.
- REPRESENTATIVE DAVID TAYLOR has traded it 5 times. They made 4 purchases worth up to $60,000 on 02/09, 01/09, 09/22 and 1 sale worth up to $15,000 on 01/29.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 2 sales worth up to $30,000 on 01/30, 12/24.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE ED CASE sold up to $15,000 on 12/01.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $50,000 on 11/06.
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
- REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 10/16.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE KATHERINE M. CLARK has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 09/17.
- REPRESENTATIVE TIM MOORE sold up to $15,000 on 09/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Procter & Gamble Hedge Fund Activity
We have seen 1,554 institutional investors add shares of Procter & Gamble stock to their portfolio, and 2,201 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 59,073,036 shares (-77.0%) from their portfolio in Q4 2025, for an estimated $8,465,756,789
- CARDANO RISK MANAGEMENT B.V. added 8,731,126 shares (+1104.8%) to their portfolio in Q4 2025, for an estimated $1,251,257,667
- BLACKROCK, INC. added 5,348,342 shares (+3.0%) to their portfolio in Q4 2025, for an estimated $766,470,892
- JPMORGAN CHASE & CO removed 4,445,304 shares (-18.0%) from their portfolio in Q4 2025, for an estimated $637,056,516
- VANGUARD GROUP INC added 2,829,151 shares (+1.2%) to their portfolio in Q4 2025, for an estimated $405,445,629
- FMR LLC added 2,755,564 shares (+11.2%) to their portfolio in Q4 2025, for an estimated $394,899,876
- ASSENAGON ASSET MANAGEMENT S.A. added 2,741,924 shares (+100.8%) to their portfolio in Q4 2025, for an estimated $392,945,128
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Procter & Gamble Analyst Ratings
Wall Street analysts have issued reports on $PG in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 01/23/2026
- Jefferies issued a "Buy" rating on 12/17/2025
- Wells Fargo issued a "Overweight" rating on 09/25/2025
To track analyst ratings and price targets for Procter & Gamble, check out Quiver Quantitative's $PG forecast page.
Procter & Gamble Price Targets
Multiple analysts have issued price targets for $PG recently. We have seen 8 analysts offer price targets for $PG in the last 6 months, with a median target of $167.5.
Here are some recent targets:
- Robert Moskow from TD Cowen set a target price of $156.0 on 01/27/2026
- Andrea Teixeira from JP Morgan set a target price of $165.0 on 01/23/2026
- Chris Carey from Wells Fargo set a target price of $165.0 on 01/23/2026
- Peter Grom from UBS set a target price of $170.0 on 01/23/2026
- Kaumil Gajrawala from Jefferies set a target price of $179.0 on 12/17/2025
- Olivia Tong from Raymond James set a target price of $175.0 on 10/20/2025
- Olivia Tong from B of A Securities set a target price of $174.0 on 10/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
